XML 50 R38.htm IDEA: XBRL DOCUMENT v3.25.3
Equity - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Class of Stock [Line Items]        
Common stock, shares authorized (in shares) 280,000,000 280,000,000   280,000,000
Preferred stock, shares authorized (in shares) 50,000,000 50,000,000   50,000,000
Common stock issued in connection with stock options exercised (in shares)   8,759    
Common stock issued through the dividend reinvestment plan (in shares)   2,721 2,777  
Employee Stock Purchase Plans shares of common stock (in shares)   9,126    
Number of shares of stock grants withheld (in shares)   73,652 93,181  
Repurchases of shares (in shares)   786,797    
Forward contract indexed to issuer's equity (in shares)       3,680,000
Forward contract indexed to issuer's equity, net proceeds   $ 808,606,000    
Gross weighted average price (in dollars per share)       $ 226.52
Restricted Stock and Common Stock Converted from Performance Shares        
Class of Stock [Line Items]        
Equity instruments granted (in shares)   182,815 250,806  
Restricted stock        
Class of Stock [Line Items]        
Equity instruments granted (in shares)   79,483 104,081  
Stock issued during period, shares, share-based compensation, forfeited (in shares)   2,681 4,021  
2020 Stock Repurchase Program        
Class of Stock [Line Items]        
Stock repurchase program, authorized amount $ 500,000,000 $ 500,000,000    
Average cost for shares Acquired (in dollars per share) $ 192.99      
Treasury stock value $ 151,846,000      
Stock repurchase program, remaining authorized amount 162,407,000 162,407,000    
Continuous Equity Program CEP V        
Class of Stock [Line Items]        
Maximum value of shares of common stock that can be sold $ 1,000,000,000 $ 1,000,000,000    
Forward contract indexed to issuer's equity (in shares)       367,113
Forward contract indexed to issuer's equity, net proceeds       $ 80,687,000
Gross weighted average price (in dollars per share)       $ 223.27
Common stock sold under CEP V (in shares) 0 0    
Common stock value, remaining to be authorized under continuous equity program $ 623,997,000 $ 623,997,000